TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Proportion stunted at 24 months of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall clinical score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in QMG scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in MG-ADL scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in FIQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dietary adherence level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity adherence level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of anaerobic flora
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Patient activation for health care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-assessed general health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Likelihood of paid employment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Total score of Y-BOCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obsession subscale of Y-BOCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compulsion subscale of Y-BOCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of completed categories subscale of WCST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fit Factors (FFs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: QNFT pass rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Detection of dysplastic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: False Negative Rate (FNR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Recurrence rate at 10 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for additional uterotonic agents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total ADOS‐2 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SRS‐2 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Costs per recovered child
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Variability in mood symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal function indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Patient awareness of disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in SRH knowledge, skills and motivations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delayed age at the first sexual encounter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: breast milk feeding at six months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: improving cervical range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reducing neck disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: total neck strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: neck strength into extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: left side flexion strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: right side flexion strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: L3 SMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: RSMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Brain glucose metabolism in limbic structures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left PFC P60 modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LICI group effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stress level associated with music performance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: anxiety level associated with music performance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: outpatient development of HF
Endpoint domain: Mortality/survival
Primary endpoint: New HE cases
Endpoint domain: Adverse events/effects
Primary endpoint: OHSI values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Daily use of emollients
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Time to treatment switch progression (TTSP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thyroid autoantibody positivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Score increase from pretest to post-test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mapping plus ablation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Psychotomimetic symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of incorrect surgical counts
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in SCWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in TMT-B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Lower HbO2 concentration in prefrontal cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement of symptoms in children with AN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician competency and comfort metrics
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Immediate Recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: new lesion frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PIM (Postpartum Intimate Partner Violence)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cavg (average concentration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of the N-back task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reaction time of the RVP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Job stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Risk of disease progression leading to hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: joint pain and swelling scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stable stage duration of gout
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with more than two points decrease in the PIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean stay time
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: rate of severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Mechanical pain thresholds around the skin incision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of hyperalgesia around the skin incision
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in episiotomy wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Improvement in active PIP extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Intraoperative cessation of remifentanil administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remifentanil administration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS-pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NTX-I level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: RNL
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Symptom reduction (anxiety, stress, cardiac anxiety, posttraumatic stress)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Efficacy against C. felis and C. canis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduction of flea egg-laying
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cmax and AUC0-∞
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUEC0-t and Emax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remission of primary anxiety disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rates of change in diagnostic severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parent-reported anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: child-reported anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: life interference due to anxiety
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Symptom improvement of belching
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: MRI erosion progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: joint space narrowing progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: achievement of stringent remission
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Treatment-related myelosuppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Glove perforation proportion
Endpoint domain: Adverse events/effects
Primary endpoint: Safety profile of GDC-0134
Endpoint domain: Adverse events/effects
Primary endpoint: RDQ disability scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Back pain on a 100-mm VAS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative probabilities for reoperation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Facial pain/pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mineral loss in the deeper region of the lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depth of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inhibition of MMP-2 and MMP-9 activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical outcomes after AC resection arthroplasty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery from anosmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery from ageusia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of ageusia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of developing SAM
Endpoint domain: Mortality/survival
Primary endpoint: Healthy MUAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in risk of self/other harm symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Higher rates of recovery and clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antigen-specific antibody concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: disturbances in self-regulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CROM scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moderate or severe bleeding events until hospital discharge
Endpoint domain: Adverse events/effects
Primary endpoint: Surgical complications within 90 days
Endpoint domain: Adverse events/effects
Primary endpoint: estimated glomerular filtration rate (eGFR) < 50 ml/min/1.73 m2 or treated biopsy-proven acute rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: incidence of BK virus and cytomegalovirus infections
Endpoint domain: Adverse events/effects
Primary endpoint: 90-day ordinal mRS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-rater reliability of severity scores
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in pre- and post-test scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: acoustic voice outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aerodynamic voice outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PrI incidence
Endpoint domain: Mortality/survival
Primary endpoint: Repositioning compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OAFQ-C scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minor complications requiring cast change or removal
Endpoint domain: Adverse events/effects
Primary endpoint: Perceived normal walking
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Decrease in impulsivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of malocclusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in serum blood urea nitrogen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: behaviour
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: febrile transfusion reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Power output at the moderate‐to‐heavy intensity transition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate associated with the moderate‐to‐heavy intensity transition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rescue analgesic medication intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Downregulation of PKA and ERK
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: motor fatigability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative progression of SUI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UVJ descent values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delayed post-papillectomy bleeding rate
Endpoint domain: Adverse events/effects
Primary endpoint: Post-procedure pancreatitis rates
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of tumor persistence
Endpoint domain: Adverse events/effects
Primary endpoint: Mucociliary clearance (MCC) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of AZD5634
Endpoint domain: Adverse events/effects
Primary endpoint: Relief of throat pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief of difficulty swallowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief of throat swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean LN count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TWH policies and programs score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PCPs' role perception regarding end-of-life care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: overall quality of communication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: quality in shared decision-making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinically significant decisional conflict (CSDC)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Response rates (≥50% decrease in MADRS score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: abnormal increase of cholestasis-related liver indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Improvement in management of individuals with PS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General health and social participation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Increase in serum BDNF concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hot flushes (HFs)
Endpoint domain: Adverse events/effects
Primary endpoint: Suppression of free T, PSA, and FSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of patients suffering related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of infections per year after switching to IRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Detection of cortical lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reliability of imaging technique (ICC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision and recall of lesion detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: REEDA score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: VSS score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: VAS score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Satisfaction with medication's effect on constipation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confidence in bowel movement frequency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Predictability of bowel habits
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression of Alzheimer's disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: knee extension 1RM improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle density increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mammography uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: exacerbation of urinary symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: mean pain score at insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chance of experiencing severe pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete cure rates
Endpoint domain: Mortality/survival
Primary endpoint: Migration of femoral components
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subsidence of tibial components
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of radiolucent lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bench 1RM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe hypokalaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hypomagnesaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: emotion recognition scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median VAS (Visual Analog Scale) for pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median daily analgesic consumption of oral tramadol (mg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of CPR performance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes